Pharmafile Logo

Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026

June 18, 2026 | ASCO, Congress, Pharma, healthcare, oncology, webinar 

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

- PMLiVE

Join our team for an expert debrief from ASCO® 2026. With a front-row seat across multiple client engagements, we’ll share the scientific highlights, attendee perspectives and strategic lessons from one of oncology’s most important annual gatherings, while exploring what smarter, more measurable congress engagement looks like in practice.

What we’ll cover

  • Key scientific and strategic themes emerging from ASCO® 2026
  • Attendee perspectives and trends shaping oncology congress engagement
  • Lessons from real-world client engagements and launch environments
  • Smarter approaches to congress strategy, engagement and measurement
  • Opportunities to drive sharper strategic decision-making through congress insights

The experts shaping the conversation

  • Mark Jackson, Managing Director, Emota, an Inizio Engage company
  • Matt Hoelzle, Chief Medical Officer, Inizio Evoke
  • Simon Davenport, Global Head of Exhibitions and Environments, Emota, an Inizio Engage company
  • Nick Bellomo, Director of Technology and Engagement, Inizio Medical
  • Jo Ann Saitta, Global Head of Data Strategy, Analytics, and AI, Inizio Ignite
  • Lynsey Holbrook, Global Client Development Director, Emota, an Inizio Engage company
Watch the webcast here.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Rare diseases and orphan drugs: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs, which includes links to…

Conducting research for publication video

APAC Director Pei Li Teh explains how real world insights provide an opportunity for brands to find, demonstrate and communicate their real value to patients, healthcare and society.Watch the video: https://bit.ly/2OcOWNu

Conference research case study

How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event

Portfolio analysis: Using market research to master communications across a therapeutic category

Many of us are familiar with billiard games, where two players compete to be the first to pocket all the balls on the table in a particular order.  We recently…

EphMRA round up 2018

EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.

Patients’willingness to pay

Considerations when developing an appropriate pricing strategy in self-pay markets

Research Partnership launches new patient Living with Diabetes (LATAM) 2018 report

Living with Diabetes is a study conducted amongst approximately 200 Type 2 (T2D) diabetes patients in Brazil and Mexico. The report will consist of quantitative 30-minute online and qualitative telephone…

Scratching the surface: unmet needs in psoriasis

Director Mariel Metcalfe shares some key findings from a recent Living with psoriasis study conducted in Europe, which is now available to purchase.Psoriasis is a skin condition but its impact…

Shift to preventative healthcare – Opportunities for screening, diagnostics and vaccination

Across emerging markets we are seeing a shift towards prevention in healthcare policy, as governments seek to contain spiraling treatment costs.There is a growing, if long overdue, recognition among policy-makers…

Conference Live for ongoing congress performance measurement

Director John Branston discusses the benefits of a mobile approach for evaluating medical conferences year-on-year